YMAB - Y-mAbs Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.71
DETAILS
HIGH:
$24.00
LOW:
$8.60
MEDIAN:
$8.60
CONSENSUS:
$12.71
UPSIDE:
47.62%
Market Cap:
391.22M
Volume:
760,675
Avg Volume:
905,066
52 Week Range:
3.55-16.11
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.53
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
104
IPO Date:
2018-09-21